Lusedra

Active Ingredient(s): Fospropofol Disodium
FDA Approved: * December 12, 2008
Pharm Company: * EISAI MEDCL RES
Category: Intravenous (IV) Therapy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lusedra Overview

Fospropofol (INN[3]), often used as the disodium salt (trade name Lusedra[4]) is an intravenous sedative-hypnotic agent. It is currently approved for use in sedation of adult patients undergoing diagnostic or therapeutic procedures such as endoscopy. Contents 1 Clinical applications 2 Clinical pharmacology 2.1 Mechanism of action 2.2 Pharmacodynamics 2.3 Pharmacokinetics 3 Controlled substance 4 References 5 Further reading Clinical applications Se...

Read more Lusedra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fospropofol

Recent Lusedra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fospropofol Disodium
  • Injection: 35mg/ml
  • Solution: 1050mg/30ml (35mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lusedra: (1 result)

Sorted by National Drug Code
  • 62856-350 Lusedra 35 mg/ml Intravenous Injection by Eisai, Inc

Other drugs which contain Fospropofol Disodium or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA